ScreenerHero

XRTXXORTX Therapeutics Inc. Common Stock

NAS · US · Healthcare · Biotechnology · xortx.com
2.040USDMkt Cap: 3.71M $P/E: —

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Pha…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap3.71M $
Enterprise Value2.77M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-2.66M $
Revenue/Share—
Last Price2.040 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)2.52
PEG—
EV/EBITDA-1.14
EV/Revenue—
P/S—
P/B1.35
EPS (TTM)-2.58
EPS (Forward)0.80
52W Range
2.033100% of range2.040
52W High2.040 USD
52W Low2.033 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-127.43%
ROA-98.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.77M $
CapEx (TTM)55.22K $
FCF Margin—
FCF Yield-43.71%
Net Debt-235.22K $
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.02
Current Ratio0.86
Quick Ratio0.37
Book Value/Sh1.497 USD
Cash/Share0.1800 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateApr 6, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.82M
Float1.37M
Insiders7.83%
Institutions4.35%
Short Interest
Short Ratio1.4d
Short % Float1.21%
Short % Out.1.19%
Shares Short20.61K
Short (prev mo.)25.04K
Technical
SMA 502.107 (-3.2%)
SMA 2002.438 (-16.3%)
Beta0.08
S&P 52W Chg21.00%
Avg Vol (30d)1.69K
Avg Vol (10d)8.22K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—